<?xml version="1.0" encoding="UTF-8"?>
<p id="Par75">After the emergence of SARS-CoV-2, around 15 potential vaccine candidates are being developed worldwide [
 <xref ref-type="bibr" rid="CR68">68</xref>]. Such vaccines are based on various technologies, including the administration of mRNA from viral surface proteins, gene vaccines, nanoparticles, and synthetic vaccines to subunits and to modified viruses [
 <xref ref-type="bibr" rid="CR69">69</xref>].
</p>
